This establishes the relevance of the intestine in influencing the susceptibility to MASH-HCC and points to intestinal LXRα activation as a driver of the metabolic environment of liver cancer in the presence of high dietary cholesterol. The gene discussed is NR1H3; the disease is hepatocellular carcinoma.